Human Immunodeficiency Virus Infection
📧 Sign up to get email alerts when something new happens for Human Immunodeficiency Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx [Phase 2]
A Phase II/III clinical trial evaluating interleukin-2 for preservation of CD4 T-lymphocytes after interruption of antiretroviral therapy in…
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: DDI Study of Etravirine and GSK1265744 [Phase 1]
A Phase 1 drug-drug interaction study evaluating etravirine with cabotegravir (GSK1265744) in healthy subjects and people with HIV has compl…
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: Yoga for the Management of HIV-Metabolic Syndromes [Phase 4]
A Phase 4 clinical trial evaluating yoga for HIV-associated metabolic and cardiovascular conditions has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body [Phase 1]
Phase 1 pharmacokinetics study to determine how PF-04776548 is cleared from the body after a micro-dose, using a radiotracer to quantify ver…
-
CLINICAL_TRIALS trial_result · 2010-01-25Clinical Trial Update: Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity [Phase 4]
Phase 4 clinical trial update evaluating whether HLA-B*5701 genetic screening can predict hypersensitivity to abacavir in HIV-infected indiv…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST) [Phase 4]
ClinicalTrials.gov update for the THIRST trial (Tuberculosis and HIV Immune Reconstitution Syndrome) Phase 4. The study has completed enroll…
-
CLINICAL_TRIALS research · 2009-10-29Clinical Trial Update: Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients [NA]
This document describes a clinical trial evaluating Immunity 1 (Fuzheng 1) for immune reconstitution in HIV/AIDS patients; the current trial…
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects [Phase 3]
Phase 3 trial comparing Lopinavir/Ritonavir tablets vs soft gel capsules and once-daily vs twice-daily dosing, coadministered with NRTIs, in…
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment [NA]
Clinical trial update examining interactions between hepatitis C viral dynamics and immune activation in patients coinfected with HIV during…
-
CLINICAL_TRIALS trial_result · 2009-04-08Clinical Trial Update: Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV) [Phase 1]
This document notes a Phase 1 safety study of the HemoModulator System for treating HIV, with the current status listed as UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2009-02-20Clinical Trial Update: A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients [NA]
This document reports the completion of a clinical trial evaluating a ritonavir/indinavir combination in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) Study [NA]
Results from the completed IMAGE study evaluate whether a microfinance-based intervention can reduce HIV risk and improve gender equity.
-
CLINICAL_TRIALS trial_result · 2009-01-29Clinical Trial Update: A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. [Phase 1, Phase 2]
A Phase 1/2 pilot study evaluated the safety and immunologic activity of AGS-004, an autologous HIV immunotherapeutic agent, in HIV-infected…
-
FDA approval · 2008-08-11FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) by Gilead Sciences, Inc., updating the product's labe…
-
CLINICAL_TRIALS trial_result · 2008-08-08Clinical Trial Update: A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC) [Phase 1]
A Phase 1 study evaluating the combination of zalcititabine (dideoxycytidine) and zidovudine for AIDS or AIDS-related complex; the trial sta…
-
FDA approval · 2008-07-30FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2008-06-06Clinical Trial Update: AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers [Phase 2]
Phase 2 trial assessing the immunogenicity and safety of three doses of a lipopeptide vaccine for HIV prevention, compared with placebo, in …
-
CLINICAL_TRIALS research · 2008-04-18Clinical Trial Update: Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDS
An observational study completed to evaluate whether intestinal parasites are associated with serum eosinophil and IgE levels in individuals…
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: Combination of Efavirenz and Truvada - COMET Study [Phase 4]
Phase 4 COMET trial evaluating the combination of efavirenz and Truvada for HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-24Clinical Trial Update: Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort [Phase 4]
Phase 4 multicenter observational cohort in Chinese patients evaluating three generic nevirapine-based antiretroviral regimens for HIV infec…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection [Phase 1]
Phase I protocol to evaluate the safety and immunogenicity of a synthetic HIV envelope peptide vaccine in patients with early HIV infection.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: GW873140 to Treat HIV-1 Infected Adults [Phase 2]
A Phase 2 clinical trial evaluating GW873140 for HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-24Clinical Trial Update: A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) [Phase 1]
This Phase 1 study evaluates the safety and immunogenicity of the epitope-based DNA vaccine EP HIV-1090 in HIV-1 infected individuals receiv…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating Vaccine in Adults With HIV [Phase 1]
Wyeth, now a wholly owned subsidiary of Pfizer, completed a Phase 1 trial evaluating an HIV vaccine in adults.
-
CLINICAL_TRIALS research · 2007-02-27Clinical Trial Update: Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific
A clinical trial funded by the National Institute of Mental Health aims to determine the prevalence of HIV-related neurological disorders in…